Xinzhuo Wang1,2, Odile Fargier-Bochaton2, Giovanna Dipasquale2, Mohamed Laouiti2,3, Melpomeni Kountouri2, Olena Gorobets4, Nam P Nguyen5, Raymond Miralbell6,7,8, Vincent Vinh-Hung2,4. 1. Radiation Oncology, Tianjin Union Medical Center, 300121, Tianjin, China. 2. Radiation Oncology Department, Geneva University Hospital, Geneva, Switzerland. 3. Service de radio-oncologie, Hôpital Riviera-Chablais, Rennaz, Switzerland. 4. CHU de Martinique, Fort-de-France, Martinique, France. 5. Howard University, Washington DC, USA. 6. Radiation Oncology Department, Geneva University Hospital, Geneva, Switzerland. raymond.miralbell@unige.ch. 7. Proton Therapy Centre, Quirónsalud, Madrid, Spain. raymond.miralbell@unige.ch. 8. Institut Oncològic Teknon (IOT), Barcelona, Spain. raymond.miralbell@unige.ch.
Abstract
PURPOSE: The advantage of prone setup compared with supine for left-breast radiotherapy is controversial. We evaluate the dosimetric gain of prone setup and aim to identify predictors of the gain. METHODS: Left-sided breast cancer patients who had dual computed tomography (CT) planning in prone free breathing (FB) and supine deep inspiration breath-hold (DiBH) were retrospectively identified. Radiation doses to heart, lungs, breasts, and tumor bed were evaluated using the recently developed mean absolute dose deviation (MADD). MADD measures how widely the dose delivered to a structure deviates from a reference dose specified for the structure. A penalty score was computed for every treatment plan as a weighted sum of the MADDs normalized to the breast prescribed dose. Changes in penalty scores when switching from supine to prone were assessed by paired t-tests and by the number of patients with a reduction of the penalty score (i.e., gain). Robust linear regression and fractional polynomials were used to correlate patients' characteristics and their respective penalty scores. RESULTS: Among 116 patients identified with dual CT planning, the prone setup, compared with supine, was associated with a dosimetric gain in 72 (62.1%, 95% CI: 52.6-70.9%). The most significant predictors of a gain with the prone setup were the breast depth prone/supine ratio (>1.6), breast depth difference (>31 mm), prone breast depth (>77 mm), and breast volume (>282 mL). CONCLUSION: Prone compared with supine DiBH was associated with a dosimetric gain in 62.1% of our left-sided breast cancer patients. High pendulousness and moderately large breast predicted for the gain.
PURPOSE: The advantage of prone setup compared with supine for left-breast radiotherapy is controversial. We evaluate the dosimetric gain of prone setup and aim to identify predictors of the gain. METHODS: Left-sided breast cancerpatients who had dual computed tomography (CT) planning in prone free breathing (FB) and supine deep inspiration breath-hold (DiBH) were retrospectively identified. Radiation doses to heart, lungs, breasts, and tumor bed were evaluated using the recently developed mean absolute dose deviation (MADD). MADD measures how widely the dose delivered to a structure deviates from a reference dose specified for the structure. A penalty score was computed for every treatment plan as a weighted sum of the MADDs normalized to the breast prescribed dose. Changes in penalty scores when switching from supine to prone were assessed by paired t-tests and by the number of patients with a reduction of the penalty score (i.e., gain). Robust linear regression and fractional polynomials were used to correlate patients' characteristics and their respective penalty scores. RESULTS: Among 116 patients identified with dual CT planning, the prone setup, compared with supine, was associated with a dosimetric gain in 72 (62.1%, 95% CI: 52.6-70.9%). The most significant predictors of a gain with the prone setup were the breast depth prone/supine ratio (>1.6), breast depth difference (>31 mm), prone breast depth (>77 mm), and breast volume (>282 mL). CONCLUSION: Prone compared with supine DiBH was associated with a dosimetric gain in 62.1% of our left-sided breast cancerpatients. High pendulousness and moderately large breast predicted for the gain.
Entities:
Keywords:
Cardiotoxicity prevention; Dose volume histogram; Linear models; Mean absolute dose deviation; Radiation dosage; Weighted excess dose deviation score
Authors: Katelyn A Raj; Elizabeth S Evans; Robert G Prosnitz; Brian P Quaranta; Patricia H Hardenbergh; Donna R Hollis; Kim L Light; Lawrence B Marks Journal: Cancer J Date: 2006 Jul-Aug Impact factor: 3.360
Authors: Thomas Mulliez; Liv Veldeman; Bruno Speleers; Khalil Mahjoubi; Vincent Remouchamps; Annick Van Greveling; Monique Gilsoul; Dieter Berwouts; Yolande Lievens; Rudy Van den Broecke; Wilfried De Neve Journal: Radiother Oncol Date: 2014-12-09 Impact factor: 6.280
Authors: Sylvia Verbanck; Shane Hanon; Daniel Schuermans; Hilde Van Parijs; Vincent Vinh-Hung; Geertje Miedema; Dirk Verellen; Guy Storme; Christel Fontaine; Jan Lamote; Mark De Ridder; Walter Vincken Journal: Int J Radiat Oncol Biol Phys Date: 2016-02-06 Impact factor: 7.038
Authors: C Bouchardy; E Rapiti; M Usel; S Balmer Majno; G Vlastos; S Benhamou; R Miralbell; I Neyroud-Caspar; H M Verkooijen; V Vinh-Hung Journal: Ann Oncol Date: 2009-08-24 Impact factor: 32.976
Authors: C Simonetto; H Rennau; J Remmele; S Sebb; P Kundrát; M Eidemüller; U Wolf; G Hildebrandt Journal: Strahlenther Onkol Date: 2018-10-22 Impact factor: 3.621
Authors: Hilde Van Parijs; Vincent Vinh-Hung; Christel Fontaine; Guy Storme; Claire Verschraegen; Dung M Nguyen; Nele Adriaenssens; Nam P Nguyen; Olena Gorobets; Mark De Ridder Journal: BMC Cancer Date: 2021-11-04 Impact factor: 4.430